Kyntra Bio, Inc. (KYNB)
8.41
-0.12
(-1.41%)
USD |
NASDAQ |
Sep 03, 10:42
Kyntra Bio Research and Development Expense (TTM) : 22.86M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.86M |
| March 31, 2026 | 21.91M |
| December 31, 2025 | 23.52M |
| September 30, 2025 | 23.12M |
| June 30, 2025 | 41.88M |
| March 31, 2025 | 68.38M |
| December 31, 2024 | 95.69M |
| September 30, 2024 | 137.53M |
| June 30, 2024 | 178.75M |
| March 31, 2024 | 241.87M |
| December 31, 2023 | 279.87M |
| September 30, 2023 | 292.79M |
| June 30, 2023 | 306.77M |
| March 31, 2023 | 282.26M |
| December 31, 2022 | 296.79M |
| September 30, 2022 | 349.08M |
| June 30, 2022 | 349.78M |
| March 31, 2022 | 401.38M |
| December 31, 2021 | 387.04M |
| September 30, 2021 | 351.26M |
| June 30, 2021 | 333.85M |
| March 31, 2021 | 272.70M |
| December 31, 2020 | 252.92M |
| September 30, 2020 | 231.59M |
| June 30, 2020 | 223.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 213.67M |
| December 31, 2019 | 209.26M |
| September 30, 2019 | 222.75M |
| June 30, 2019 | 229.23M |
| March 31, 2019 | 229.36M |
| December 31, 2018 | 235.84M |
| September 30, 2018 | 218.02M |
| June 30, 2018 | 211.92M |
| March 31, 2018 | 206.76M |
| December 31, 2017 | 196.52M |
| September 30, 2017 | 194.66M |
| June 30, 2017 | 184.88M |
| March 31, 2017 | 190.29M |
| December 31, 2016 | 187.21M |
| September 30, 2016 | 196.52M |
| June 30, 2016 | 208.04M |
| March 31, 2016 | 207.20M |
| December 31, 2015 | 214.09M |
| September 30, 2015 | 205.42M |
| June 30, 2015 | 193.97M |
| March 31, 2015 | 175.68M |
| December 31, 2014 | 150.79M |
| September 30, 2014 | 117.56M |
| June 30, 2014 | 92.01M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vericel Corp. | 29.17M |
| Capricor Therapeutics, Inc. | 98.66M |
| ARS Pharmaceuticals, Inc. | 15.23M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| Alnylam Pharmaceuticals, Inc. | 1.509B |